PharmaCyte Biotech Inc. (PMCB) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    PharmaCyte Biotech Inc.

    NASDAQ: PMCB · Real-Time Price · USD
    1.06
    -0.07 (-6.19%)
    At close: Sep 09, 2025, 3:59 PM
    1.12
    5.66%
    After-hours: Sep 09, 2025, 07:20 PM EDT

    PharmaCyte Biotech Income Statement

    Financials in USD. Fiscal year is May - April.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Apr 30, 2025 Apr 30, 2024 Apr 30, 2023 Apr 30, 2022 Apr 30, 2021
    Revenue
    		 n/a n/a n/a n/a n/a
    Cost of Revenue
    		 n/a n/a n/a n/a n/a
    Gross Profit
    		 n/a n/a n/a n/a n/a
    Operating Income
    		 -4,377.9B -6.52M -6.46M -4.39M -3.62M
    Interest Income
    		 1.42M 3.4M 1.94M 157.65K 3.05
    Pretax Income
    		 23,362.1B 333.76K -4.32M -4.24M -3.55M
    Net Income
    		 30.66M 333.76K -4.32M -4.24M -3.55M
    Selling & General & Admin
    		 3.94M 6.11M 5.99M 3.7M 2.71M
    Research & Development
    		 438.42K 407.43K 468.54K 690.94K 916.25K
    Other Expenses
    		 n/a -8 -494 -14 -249
    Operating Expenses
    		 4.38M 6.52M 6.46M 4.39M 3.62M
    Interest Expense
    		 n/a n/a n/a 509.00 3.05K
    Selling & Marketing Expenses
    		 n/a 1.32M 1.23M 1.54M n/a
    Cost & Expenses
    		 4.38M 6.52M 6.46M 4.39M 3.62M
    Income Tax Expense
    		 n/a n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 7.33M 9.58M 19.49M 15.52M 1.45M
    Shares Outstanding (Diluted)
    		 7.33M 9.58M 5.18M 5.18M 1.45M
    EPS (Basic)
    		 3.19 -1.8 -0.22 -0.27 -2.46
    EPS (Diluted)
    		 3.19 -1.8 -0.83 -0.79 -2.46
    EBITDA
    		 30.66M 333.76K -4.32M -4.24M -3.55M
    EBIT
    		 30.66M 333.76K -6.46M -4.24M -3.55M
    Depreciation & Amortization
    		 n/a 6.52M 6.46M n/a n/a

    Add to Watchlist